302 results
8-K
LFCR
Lifecore Biomedical Inc
30 Apr 24
Changes in Registrant's Certifying Accountant
5:06pm
. (the “Company”) approved the engagement of BDO USA, P.C. (“BDO”) as the Company’s independent registered public accounting firm, effective immediately
NT 10-Q
LFCR
Lifecore Biomedical Inc
8 Apr 24
Notice of late quarterly filing
4:25pm
LLP (“EY”), the Company’s independent registered public accounting firm for the fiscal year ended May 28, 2023, notified the Company had determined … that it declined to stand for reappointment as the Company’s independent registered public accounting firm for the Company’s fiscal year ending May 26
8-K
EX-99.1
LFCR
Lifecore Biomedical Inc
1 Apr 24
Results of Operations and Financial Condition
8:07am
. No independent registered public accounting firm has audited, reviewed, compiled or applied agreed-upon procedures with respect to these preliminary
8-K
EX-99.2
LFCR
Lifecore Biomedical Inc
1 Apr 24
Results of Operations and Financial Condition
8:07am
reliance on these preliminary estimates. These preliminary estimates have been prepared by, and are the responsibility of, our management. No independent … estimates have been prepared by and are the responsibility of management. No independent registered public accounting firm has audited, complied
8-K
LFCR
Lifecore Biomedical Inc
26 Mar 24
Changes in Registrant's Certifying Accountant
4:32pm
notice from Ernst & Young LLP (“Ernst & Young”), the Company’s independent registered public accounting firm for the fiscal year ended May 28, 2023 … , that Ernst & Young had determined that it declined to stand for reappointment as the Company’s independent registered public accounting firm
8-K
EX-10.3
t1f6vkaoh
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
8-K
EX-99.1
e0d9ta3gv486
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
8-K
EX-10.2
i6ab253kg
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
8-K
EX-10.3
ux69rykbd2us3 f2bzh
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
8-K
rxur2x2 5jpai4h
31 Oct 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
6:17am
424B3
n51hwu9
9 Jun 23
Prospectus supplement
4:31pm
S-1/A
4qn8h
6 Jun 23
IPO registration (amended)
4:54pm
S-1/A
EX-23.1
hws 08e9ri
6 Jun 23
IPO registration (amended)
4:54pm
8-K
EX-10.3
ulfzbkq00 q0
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.1
d7raz644kbh99mtxd3s
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.6
dj7kntxc2 kb9pbnda
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm